← FDA Drug Approvals (Drugs@FDA)
VORICONAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UBI · Approved 2023-03-09
Drug application
- FDA Application #
ANDA211264- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- VORICONAZOLE
- Generic name
- VORICONAZOLE
- Active ingredients
- VORICONAZOLE
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- UBI
- Manufacturer
- UBI Pharma Inc.
- First approval
- 2023-03-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown